Boehringer Ingelheim Patents

Patent portfolio assigned to Boehringer Ingelheim (verified via public assignee records). Estimated patent count: 439. Pharma/animal-health company (B2B/B2C drugs, not named clients). Patent count is USPTO granted (439 of 738 filings) per GreyB; Zoetis/Elanco are animal-health competitors. Sanofi also appears as a Workday customer separately.